Direct-acting antivirals for RSV treatment, a review
B Bonneux, E Jacoby, M Ceconi, K Stobbelaar… - Antiviral Research, 2024 - Elsevier
Respiratory syncytial virus (RSV) causes respiratory disease and complications in infants,
the elderly and the immunocompromised. While three vaccines and two prophylactic …
the elderly and the immunocompromised. While three vaccines and two prophylactic …
Recent progress toward the discovery of small molecules as novel anti-respiratory syncytial virus agents
T Felicetti, C Sarnari, R Gaito, O Tabarrini… - Journal of Medicinal …, 2024 - ACS Publications
Respiratory syncytial virus (RSV) stands as the foremost cause of infant hospitalization
globally, ranking second only to malaria in terms of infant mortality. Although three vaccines …
globally, ranking second only to malaria in terms of infant mortality. Although three vaccines …